Financial

News

Now feeling the impact of generic competition on its top product Entresto in the US, Novartis is still looking for pipeline-building deals, says CEO.

News

Germany's Stada has said it may make another attempt to seek a public listing in the autumn, after delaying its plans earlier this year.

News

Facing declines in flu vaccination rates in the US, CSL will spin out its vaccine unit as part of a wider restructuring that will claim 3,000 jobs.

News

Iovance will slash 19% of its headcount in a restructuring that follows slower-than-expected sales growth for melanoma cell therapy Amtagvi.

News

Shares in Eli Lilly have come under pressure after reporting the results of a phase 3 trial of oral weight-loss candidate orforglipron.

News

The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – and isn't yet completed.